SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (15385)6/21/2001 9:48:14 PM
From: Cacaito  Read Replies (2) | Respond to of 17367
 
I am amazed at the anti xoma campaign success so far... it
is ridiculous that after so much hard work to get a very good drug to complete trials and relatively soon to marketing success, a selloff of the stock is ongoing virulently.

Ludicrous that the pinnacle work turns into a disaster, albeit a "short" term one. It should recovered well shortly after these, maybe not too far from here.



To: Cacaito who wrote (15385)6/21/2001 10:04:00 PM
From: Bluegreen  Read Replies (1) | Respond to of 17367
 
Cacaito, so do you think there is no room for more than one drug for psoriasis? Our commander in chief Jack Castello talks about OTHER INDICATIONS. YEEEEEEEEEEEEEHAWWWWWWWWW......now could that be RA?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News